HCW Biologics Inc. logo

HCW Biologics Inc.

HCWB | NASDAQ
Chart Builder DCF Calculator
$1.91
+$0.04 (+2.14%)
At close: Sep 21, 2026, 4:00 PM ET
$1.97
+$0.06 (+3.07%)
Pre-market: Sep 22, 2026, 4:38 AM ET

Market Data

Market Cap
$650.09K
Enterprise Value
$6.48M
Beta
2.38
Average Volume
2.05M
Shares Outstanding (Diluted)
1.33M
Shares Change YoY
347.6%
Institutional Ownership
21.44%
Exchange
NASDAQ
ISIN
US40423R3030

Price Performance

Price Change 1M
-17.7%
Price Change 3M
-70.5%
Price Change 6M
-18.4%
Price Change YTD
-71.6%
Price Change 1Y
-92.1%
Price Change 3Y
-99.6%
Price Change 5Y
-99.8%
1M CAGR (ann.)
-45.2%
1Y CAGR (ann.)
-92.8%
5Y CAGR (ann.)
-71.7%
All-Time CAGR
-72.6%

Valuation

PE Ratio
-0.09
Forward PE
N/A
PEG Ratio
0.00
Forward PEG
0.00
PS Ratio
0.10
Forward PS
0.00
PB Ratio
0.09
P/FCF Ratio
-0.05
P/Adj. FCF Ratio
-0.05
P/OCF Ratio
-0.06
EV/Sales
0.96
EV/EBIT
28.51
EV/EBITDA
-2.63
EV/FCF
-0.53
Earnings Yield
-1140.3%
FCF Yield
-1827.8%
Adj. FCF Yield
-1830.9%

Financial Health

Net Debt
$5.82M
Total Debt
$6.56M
Cash & Short-Term Investments
$741.32K
Total Assets
$26.77M
Current Ratio
0.06
Quick Ratio
0.06
Debt / Equity Ratio
0.88
Debt / EBITDA
-2.66
Debt / FCF
-0.54
OCF / Debt
-1.85
Interest Coverage
-17.08
Altman Z-Score
-6.25
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
95.9%
Operating Profit Margin
-91.6%
EBITDA Margin
-63.6%
Net Profit Margin
-73.2%
FCF Margin
-180.6%
Adj. FCF Margin
-180.9%
SBC / Revenue
0.3%
SBC Impact (per share)
-0.2%

Returns

Return on Assets
-18.4%
Return on Equity
-142.2%
Return on Invested Capital
-39.3%
Return on Capital Employed
-75.8%
Return on Tangible Assets
-18.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
20.8%
Revenue CAGR 5Y
10.4%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-33.2%
EPS CAGR 5Y
-51.3%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
32.6%
FCF CAGR 5Y
10.9%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
1
EPS Growth Next 3Y
30.6%
Revenue Growth Next 3Y
-90.2%
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$5
Price Target Upside
161.8%

Cash Flow

Operating Cash Flow
$-12.14M
Free Cash Flow
$-12.14M
Adj. Free Cash Flow
$-12.16M
FCF Per Share
-$34.71
OCF Per Share
-$34.71
OCF/S Ratio
-180.6%

Income Statement

Revenue
$6.72M
Gross Profit
$6.45M
Operating Income
$-6.15M
EBITDA
$-2.47M
Net Income
$-15.08M
EPS (Diluted)
-$21.78
Revenue / Employee
$192.03K
Profit / Employee
$-430.75K
Employees
35

© 2026 bestshares.com. All rights reserved.